Your browser doesn't support javascript.
loading
Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.
Ilca, F Tudor; Neerincx, Andreas; Wills, Mark R; de la Roche, Maike; Boyle, Louise H.
Afiliação
  • Ilca FT; Department of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
  • Neerincx A; Department of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
  • Wills MR; Department of Medicine, University of Cambridge, Addenbrookes Hospital, CB2 0QQ Cambridge, United Kingdom.
  • de la Roche M; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, CB2 0RE Cambridge, United Kingdom.
  • Boyle LH; Department of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom; lhb22@cam.ac.uk.
Proc Natl Acad Sci U S A ; 115(40): E9353-E9361, 2018 10 02.
Article em En | MEDLINE | ID: mdl-30213851
ABSTRACT
The repertoire of peptides displayed at the cell surface by MHC I molecules is shaped by two intracellular peptide editors, tapasin and TAPBPR. While cell-free assays have proven extremely useful in identifying the function of both of these proteins, here we explored whether a more physiological system could be developed to assess TAPBPR-mediated peptide editing on MHC I. We reveal that membrane-associated TAPBPR targeted to the plasma membrane retains its ability to function as a peptide editor and efficiently catalyzes peptide exchange on surface-expressed MHC I molecules. Additionally, we show that soluble TAPBPR, consisting of the luminal domain alone, added to intact cells, also functions as an effective peptide editor on surface MHC I molecules. Thus, we have established two systems in which TAPBPR-mediated peptide exchange on MHC class I can be interrogated. Furthermore, we could use both plasma membrane-targeted and exogenous soluble TAPBPR to display immunogenic peptides on surface MHC I molecules and consequently induce T cell receptor engagement, IFN-γ secretion, and T cell-mediated killing of target cells. Thus, we have developed an efficient way to by-pass the natural antigen presentation pathway of cells and load immunogenic peptides of choice onto cells. Our findings highlight a potential therapeutic use for TAPBPR in increasing the immunogenicity of tumors in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Imunoglobulinas / Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Imunoglobulinas / Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article